AI주식인사이트AI Stock Insight
C

케이엠제약

225430KOSDAQ

52.0 / 100

Reference Date: 2026-10-23

Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.

Number of Employees

63people

Average Salary

42.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.16Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-13.04Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
22.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼74.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -10.0% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 698Won52-week high 3,03552-week low 340
1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-10-08
  • Neutral기타경영사항(자율공시) (상장폐지결정 효력정지 가처분 인용 결정)2026-10-02